Amicus Therapeutics, Inc. (FRA:AM6)

Germany · Delayed Price · Currency is EUR

8.30

+0.05 (0.61%)

At close: Dec 4, 2025

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2017 - 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2017 - 2020
U.S. Revenue	247.03M	206.15M	Log In	Log In	Log In	Upgrade
Outside of U.S. Revenue	351.67M	322.15M	Log In	Log In	Log In	Upgrade
Revenue (Total)	598.70M	528.30M	Log In	Log In	Log In	Upgrade

Revenue

Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2017 - 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2017 - 2020
Galafold Revenue	498.96M	458.05M	Log In	Log In	Log In	Upgrade
Pombiliti and Opfolda Revenue	99.74M	70.24M	Log In	Log In	Log In	Upgrade
Revenue (Total)	598.70M	528.30M	Log In	Log In	Log In	Upgrade